Your session is about to expire
← Back to Search
IV Contrast-Enhanced US for Appendicitis
Phase 1
Waitlist Available
Led By Harriet Paltiel, MDCM
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Children who have had a conventional abdominal US study to rule out acute appendicitis and are scheduled for an MRI or CT examination.
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week
Awards & highlights
Summary
This study evaluates the ability of contrast-enhanced ultrasound to improve the diagnosis of acute appendicitis in children compared to conventional ultrasound.
Eligible Conditions
- Appendicitis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Contrast-enhanced ultrasound diagnosis of acute appendicitis
Trial Design
1Treatment groups
Experimental Treatment
Group I: IV Contrast-Enhanced USExperimental Treatment1 Intervention
IV sulfur hexafluoride lipid-type A microspheres, 0.03 mL/kg, 2 doses per examination, total dose not to exceed 4.8 mL. Single examination per patient.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol)
FDA approved
Find a Location
Who is running the clinical trial?
Boston Children's HospitalLead Sponsor
773 Previous Clinical Trials
5,580,951 Total Patients Enrolled
2 Trials studying Appendicitis
15,052 Patients Enrolled for Appendicitis
Harriet Paltiel, MDCMPrincipal InvestigatorBoston Children's Hospital
Share this study with friends
Copy Link
Messenger